GlobalRPh Clinical Technology Peptide Evidence Without the Hype - Peptide Selection Tool Introducing the GlobalRPh Investigational Peptide Evidence and Safety Navigator, a structured evidence mapping program that separates FDA approved peptide medicines from off label research, human investigational programs, preclinical compounds, and products supported primarily by marketing
Longevity
Senescent Cells: Therapeutic Target, Biological Signal, or Red Herring?
Senescent Cells: Therapeutic Target, Biological Signal, or Red Herring? Longevity Series Brief Summary This article explores one of the most intriguing questions in modern geroscience: whether senescent cells are actionable therapeutic targets or merely biological bystanders associated with aging and chronic disease. The answer
Healthspan vs. Lifespan: Are We Measuring the Years That Matter?
Healthspan vs. Lifespan: Are We Measuring the Years That Matter? Longevity Series Brief Summary This article explores the growing distinction between lifespan and healthspan. Lifespan asks how long people live. Healthspan asks how much of that life is lived with preserved function, independence, cognition, mobility,
Immune Aging (Immunosenescence) The Next Major Target for Longevity Medicine
Immune Aging (Immunosenescence) The Next Major Target for Longevity Medicine Abstract The human immune system undergoes gradual decline with advancing age, a process termed immunosenescence. This deterioration represents one of the most promising targets for extending healthy lifespan. Research demonstrates that immune aging contributes to
Muscle Aging and Sarcopenia: Are Senolytics the Missing Piece?
Muscle Aging and Sarcopenia: Are Senolytics the Missing Piece? Abstract Age-related muscle loss, known as sarcopenia, affects millions of older adults worldwide. This condition leads to decreased strength, mobility, and independence while increasing fall risk and mortality. Traditional treatments focus on exercise and
Ageotypes and Modern Longevity Biomarkers: What Physicians Should Monitor Beyond Telomeres
Ageotypes and Modern Longevity Biomarkers: What Physicians Should Monitor Beyond Telomeres Key Takeaways Stanford's ageotypes framework revolutionizes aging assessment by identifying four distinct aging patterns—metabolic, immune, hepatic, and nephrotic—enabling personalized longevity interventions beyond traditional approaches. • Telomeres alone are insufficient: Individual variation and tissue-specific differences
Longevity Clinics: Evidence-Based Medicine or Cash-Pay Experimentation?
Longevity Clinics: Evidence-Based Medicine or Cash-Pay Experimentation? Abstract The emergence of longevity clinics represents a growing trend in healthcare delivery, offering services aimed at extending human lifespan and improving health span. These clinics operate primarily on a cash-pay basis, providing treatments ranging from
The Internist’s Role in the Longevity Movement: Separating Science from Pseudoscience
The Internist’s Role in the Longevity Movement Separating Science from Pseudoscience Abstract The longevity movement has gained considerable traction in recent years, driven by advances in molecular biology, increased public interest in healthy aging, and widespread media coverage of anti-aging interventions. Promises of extended lifespan
Emerging and Approved Therapeutic Peptides: Mechanisms, Clinical Uses
Emerging and Approved Therapeutic Peptides: Mechanisms, Clinical Uses, Safety Profiles, and Regulatory Status Across Health Conditions Abstract Therapeutic peptides represent a rapidly growing class of pharmaceutical agents that bridge the gap between small molecule drugs and large protein therapeutics. This paper examines the
The New Frontier in Longevity Science: Senolytics and Age-Reversal Therapies
The New Frontier in Longevity Science: Senolytics and Age-Reversal Therapies Introduction Approximately 80% of adults over age 65 worldwide develop at least one chronic condition, from arthritis to dementia. Recent longevity research has identified cellular senescence as a fundamental driver of age-related decline. These
